Your Basket
Your Basket
There are no funds in your basket. To add funds to your basket use the Green Plus Icon wherever you see it next to a fund.
Fund name
Aberdeen American Growth  
Fidelity American  
Schroder UK Mid 250  
M&G Recovery  
Jupiter Merlin UK Growth  
Close Basket Open basket

Login

Login
Password Reminder
Not Registered? Click Here

Register

Register
It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
Investazine
 
Poll

Would you invest in a fund managed by someone who is nearing retirement age?

Yes
No

Vote

 
You are here: Factsheet
 
NEW FEATURE Is this feature useful? arrow Thank you for your feedback
See AXA Framlington Biotech fund as a life fund
See underlying AXA Framlington Biotech fund

Aviva AXA Framlington Biotech Pn

Underlying Fund

AXA Framlington Biotech

FE Crown Rating ( Underlying )

Fund Objective ( Underlying )

To provide long-term capital appreciation by investing principally in equity securities of companies in the biotechnology, genomics and medical research industries worldwide.

Fund Manager ( Underlying )

Linden Thomson

Domicile

United Kingdom

Sector

Specialist

Currency

GBX

Primary Asset Class

Equity

Fund Size

GBX 6.01m as at 31-Mar-2013

Unit Name

Aviva AXA Framlington Biotech Pn S6

Inc/Acc

Accumulating 

Citicode

BEI1

Initial Charge

0.00%

Unit Currency

GBX 

ISIN

GB00B2PW9H46 

Annual Charge

0.00%

Bid

GBX 257.44

Offer

GBX 0.00

Change (Offer)

-3.18 (-1.22%)
18-Jun-2013

Unit LaunchDate

07-Apr-2008

Performance Overview

Performance Charts

Cumulative Performance

  YTD 3m 6m 1y 3y 5y
Fund 31.64 6.60 29.17 39.91 93.84 152.10
Sector 6.22 -0.98 6.64 12.10 17.27 24.74
Benchmark 6.22 -0.98 6.64 12.10 17.27 24.74
 

Discrete Performance (%)

  2012 2011 2010 2009 2008
Fund 26.31 8.61 11.18 5.59 -
Sector 7.66 -4.19 9.25 19.75 -17.04
Benchmark 7.66 -4.19 9.25 19.75 -17.04

Asset Allocation ( Underlying )

breakdown chart
  Asset Class % of Fund
US Equities 87.90
Money Market 3.05
UK Equities 2.69
Irish Equities 2.29
German Equities 1.28
Swiss Equities 1.17
Swedish Equities 0.82
Spanish Equities 0.80

Regional Breakdown ( Underlying )

breakdown chart
  Region % of Fund
USA 87.90
Money Market 3.05
UK 2.69
Ireland 2.29
Germany 1.28
Switzerland 1.17
Sweden 0.82
Spain 0.80

Sector Breakdown ( Underlying )

breakdown chart
  Sector % of Fund
Biotech Product 76.54
Specialty Pharma 11.67
Enabling Technology / Tools 5.49
Cash 3.05
Drug Delivery 2.17
Devices 0.92
Healthcare Services 0.16

All prices in Pence Sterling (GBX) unless otherwise specified. Price performance figures are calculated on a bid price to bid price basis with net income (dividends) reinvested. Performance figures are shown in Sterling.

 
 
Sign up for email alerts
Stay upto date on the latest fund research from FE
 
subscribe Readers of this page also looked at:
Readers of this Factsheet have not looked at any others
 
 
 
Add your comment
 
Reload Change mode
 
Enter the words above:
Send comment
 
Be the first to comment on this Factsheet.
 

Education

Top 5 education guides

alter Absolute return
alter Multi-manager
alter Property
alter Investment trusts
alter ISAs

More education guides»

 

News & Research

Free financial guides

alter Investments trusts and share plans
alter Money guides
alter ISAs
alter Child saving plans and child trust funds

More brochures»

 
  • Stay connected with FE trustnet
  • Authorised and Regulated by the
    Financial Conduct Authority
  • © Trustnet Limited 2013. All Rights Reserved.
  • Please read our Terms of Use / Disclaimer
    and Privacy and Cookie Policy.
  • Data supplied in conjunction with Thomson Financial Limited,
    London Stock Exchange Plc, StructuredRetailProducts.com
    and ManorPark.com
What do you think about this toolbar?
Close permanently
Close for this session